Skip to main content
NIH funding notice RFA-MD-22-003

Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Closed on April 4, 2022.

Posted
January 5, 2022
Close date
April 4, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $807,651 in first-year total cost, median $275,661.

Most frequent study sections

  1. Special Emphasis Panel[ZMD1 JT (A1)]3

Most frequent institutions

  1. APPLIED UNIVERSAL DYNAMICS CORPORATION1
  2. LIFEGENE-BIOMARKS, INC.1
  3. PENDERIA TECHNOLOGIES, INC.1
Competing awards under RFA-MD-22-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas1R42MD018231-01GUERRERO-PRESTON, RAFAELLIFEGENE-BIOMARKS, INC., PR$275,767ZMD1
2024Improving Access and Automating Fitting for Hearing Aid Devices for the Underserved and Rural Populations1R41MD018220-01PAVAN, ALLALAGHATTAAPPLIED UNIVERSAL DYNAMICS CORPORATION, MN$275,661ZMD1
2023Novel Pigment Sensing Pulse Oximeter Technology for Mitigating Racial Bias in Oxygen Saturation Measurements1R41TR004320-01MCGEEHAN, MICHAELPENDERIA TECHNOLOGIES, INC., OR$256,223ZMD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MD-22-003: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) | ScienceDex | ConductScience